Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
30
pubmed:dateCreated
2007-7-26
pubmed:abstractText
Autonomous parvoviruses induce severe morphological and physiological alterations in permissive host cells, eventually leading to cell lysis and release of progeny virions. Viral cytopathic effects (CPE) result from specific rearrangements and destruction of cytoskeletal micro- and intermediate filaments. We recently reported that inhibition of endogenous casein kinase II (CKII) protects target cells from parvovirus minute virus of mice (MVM)-induced CPE, pointing to this kinase as an effector of MVM toxicity. The present work shows that the parvoviral NS1 protein mediates CKII-dependent cytoskeletal alterations and cell death. NS1 can act as an adaptor molecule, linking the cellular protein kinase CKIIalpha to tropomyosin and thus modulating the substrate specificity of the kinase. This action results in an altered tropomyosin phosphorylation pattern both in vitro and in living cells. The capacity of NS1 to induce CPE was impaired by mutations abolishing binding with either CKIIalpha or tropomyosin. The cytotoxic adaptor function of NS1 was confirmed with fusion peptides, where the tropomyosin-binding domain of NS1 and CKIIalpha are physically linked. These adaptor peptides were able to mimic NS1 in its ability to induce death of transformed MVM-permissive cells.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/17636126-10388664, http://linkedlifedata.com/resource/pubmed/commentcorrection/17636126-11112491, http://linkedlifedata.com/resource/pubmed/commentcorrection/17636126-12477848, http://linkedlifedata.com/resource/pubmed/commentcorrection/17636126-12829844, http://linkedlifedata.com/resource/pubmed/commentcorrection/17636126-1413512, http://linkedlifedata.com/resource/pubmed/commentcorrection/17636126-14610171, http://linkedlifedata.com/resource/pubmed/commentcorrection/17636126-15582663, http://linkedlifedata.com/resource/pubmed/commentcorrection/17636126-16550599, http://linkedlifedata.com/resource/pubmed/commentcorrection/17636126-16641266, http://linkedlifedata.com/resource/pubmed/commentcorrection/17636126-2167840, http://linkedlifedata.com/resource/pubmed/commentcorrection/17636126-2317800, http://linkedlifedata.com/resource/pubmed/commentcorrection/17636126-3339715, http://linkedlifedata.com/resource/pubmed/commentcorrection/17636126-8083981, http://linkedlifedata.com/resource/pubmed/commentcorrection/17636126-9311818, http://linkedlifedata.com/resource/pubmed/commentcorrection/17636126-9733839
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:day
24
pubmed:volume
104
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
12482-7
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
A viral adaptor protein modulating casein kinase II activity induces cytopathic effects in permissive cells.
pubmed:affiliation
Program "Infection and Cancer," Abteilung F010 and Institut National de la Santé et de la Recherche Médicale Unité 701, Deutsches Krebsforschungszentrum, D-69120 Heidelberg, Germany. jpf.nuesch@dkfz.de
pubmed:publicationType
Journal Article